News
Health agency warns of link between pregnancy complications and weight loss drugs
Health experts are raising concerns for women using popular weight loss medications, particularly GLP-1s like Wegovy, Zepbound, and Mounjaro. A UK health agency warns that these drugs could lead to unintended pregnancies and complications during pregnancy.
Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions ...
Eli Lilly’s Zepbound proved more effective than Novo Nordisk’s Wegovy in a new head-to-head trial, though both medications ...
Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...
THURSDAY, June 5, 2025 (HealthDay News) — More American teenagers now use the weight-loss drug Wegovy, as doctors and ...
Poison control experts say calls related to GLP-1 weight-loss drugs like Wegovy and Zepbound are rising, with symptoms like ...
The percentage of overweight or obese adults prescribed GLP-1s jumped by almost 587% between 2019 and 2024, according to a ...
The findings presented at a conference in Chicago found a slightly lower risk of obesity-related cancers when adults with ...
The report also underscored the importance of maintaining muscle mass and bone density while losing weight. Since weight loss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback